不再锚定“最低价”，国家药品集采迎八大变化

Core Viewpoint - The new centralized drug procurement policy introduces significant changes aimed at improving drug quality and ensuring better access for patients, moving away from a strict focus on the lowest price [1][3]. Group 1: Key Changes in Procurement Policy - The new procurement policy no longer anchors on the "lowest price," allowing for a more balanced approach to pricing [1][3]. - Medical institutions can report quantities based on specific drug brands, enhancing the alignment between clinical needs and procurement outcomes [13][15]. - The selection process for drugs has been made more transparent, with the criteria for inclusion in the procurement list being publicly disclosed for the first time [4][5]. Group 2: Drug Selection Criteria - A total of 55 drug varieties have been selected for the eleventh batch of procurement, following a rigorous selection process that included expert opinions [5][6]. - New drugs and those under negotiation for the first year will not be included in the procurement, ensuring that only established drugs are considered [8]. - Drugs with a projected procurement amount of less than 100 million yuan in 2024 will be excluded from the procurement list, promoting larger scale procurement [9][10]. Group 3: Quality and Safety Measures - The new policy emphasizes quality control, requiring that participating companies have at least two years of production experience in similar formulations [18]. - High-risk drugs will be excluded from the procurement process to ensure patient safety and effective clinical use [7][14]. - The procurement process will respect clinical needs, allowing for adjustments based on actual usage and seasonal demand [14][15]. Group 4: Pricing and Competition - The new policy introduces a "low-price declaration" requirement for the lowest bidding companies to justify their pricing, addressing concerns about unsustainable low bids [16][17]. - The price control mechanism will no longer simply use the lowest bid as a reference point, aiming to prevent excessive price competition [16][17]. - The procurement process will focus on rational competition, reducing the risk of "price wars" among suppliers [16][17].